Saturday 17 October 2026
Export NNVC’s income statement to Excel — free account
NanoViricides, Inc.
NNVC Healthcare Biotechnology
In the quarter to June 2026, EPS grew 24.1% and free cash flow fell 23.9%, each against the same quarter a year earlier.
1.38
0.01
+0.73%
Follow NNVC
| Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
3.28 | 8.30 | 0.99 | 6.49 | 59.31 | 34.92 | 15.81 | 3.66 | 1.28 | 2.66 |
Net Debt/EBITDA |
1.47 | 0.85 | 0.32 | 1.88 | 2.55 | 1.89 | 0.99 | 0.62 | 0.18 | 0.36 |
Debt/Assets |
14.65% | 0.00% | 0.00% | 0.26% | 0.31% | 0.40% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.77 | 0.91 | 0.81 | 0.50 | 0.93 | 0.73 | 0.66 | 0.76 | 0.90 | 0.94 |
Capex/Depreciation |
(0.08) | (0.23) | (0.11) | (0.01) | (0.33) | (0.45) | (0.20) | (0.21) | (0.08) | (0.16) |
Interest Coverage |
(12.30) | (50.32) | (156.03) | (85.34) | (102.39) | (1,590.90) | (9,937.22) | (171.01) | (95,916.00) | — |
| (47.53%) | (45.10%) | (59.62%) | (83.11%) | (34.15%) | (30.60%) | (45.27%) | (63.00%) | (99.75%) | (101.46%) | |
| (32.39%) | (37.60%) | (52.66%) | (71.98%) | (32.57%) | (30.16%) | (42.52%) | (55.81%) | (87.47%) | (87.91%) | |
ROIC |
(65.37%) | (55.07%) | (67.27%) | (61.61%) | (57.59%) | (55.66%) | (83.23%) | (79.84%) | (100.60%) | (88.16%) |
Return on Tangible Assets |
(47.06%) | (49.55%) | (82.56%) | (62.91%) | (29.85%) | (35.72%) | (53.62%) | (74.56%) | (131.52%) | (98.15%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.01 | 0.02 | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | 0.03 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(2.68) | (2.47) | (1.92) | (1.19) | (0.78) | (0.54) | (0.50) | (0.55) | (0.56) | (0.39) |
Cash per Share |
5.02 | 2.18 | 0.71 | 2.44 | 1.88 | 1.22 | 0.70 | 0.40 | 0.10 | 0.14 |
Shareholders Equity per Share |
6.76 | 5.44 | 2.95 | 3.87 | 2.74 | 2.00 | 1.28 | 0.97 | 0.50 | 0.43 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.76 | 5.44 | 2.95 | 3.87 | 2.74 | 2.00 | 1.28 | 0.97 | 0.50 | 0.43 |
Free Cash Flow |
(8.06) | (8.02) | (6.88) | (6.67) | (8.45) | (6.22) | (5.82) | (6.47) | (8.54) | (7.78) |
Working Capital |
10.62 | 6.44 | (0.02) | 11.83 | 20.47 | 14.00 | 7.91 | 3.61 | 0.36 | 1.97 |
Capital Expenditures |
(0.16) | (0.24) | (0.07) | (0.01) | (0.24) | (0.32) | (0.15) | (0.16) | (0.06) | (0.08) |
Net Current Asset Value |
8.61 | 6.44 | (0.02) | 11.83 | 20.47 | 14.00 | 6.41 | 3.61 | 0.36 | 1.97 |
| Other line items | ||||||||||
Quick Ratio |
3.24 | 8.03 | 0.90 | 6.36 | 58.44 | 34.08 | 15.25 | 3.53 | 1.19 | 2.35 |
Depreciation/Fixed assets |
0.18 | 0.10 | 0.07 | 0.08 | 0.08 | 0.08 | 0.09 | 0.10 | 0.11 | 0.08 |
Cash ROIC |
(20.48%) | (32.40%) | (52.27%) | (18.79%) | (16.73%) | (16.69%) | (25.30%) | (39.80%) | (94.04%) | (67.79%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2.63) | (2.40) | (1.89) | (1.19) | (0.75) | (0.51) | (0.49) | (0.53) | (0.56) | (0.38) |
Capex per Share |
(0.05) | (0.07) | (0.02) | 0.00 | (0.02) | (0.03) | (0.01) | (0.01) | 0.00 | 0.00 |
Average Payables |
0.67 | 0.40 | 0.73 | 1.04 | 0.59 | 0.25 | 0.33 | 0.74 | 1.19 | 1.22 |
Average Assets |
31.82 | 22.77 | 16.00 | 18.68 | 27.09 | 26.88 | 20.20 | 14.86 | 10.82 | 9.35 |
Average Common Equity |
21.68 | 18.99 | 14.13 | 16.18 | 25.83 | 26.50 | 18.97 | 13.16 | 9.49 | 8.10 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 30 Sep 2026